KFH - OC-ANAHEIM
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2.9M
- Transactions
- 115
- Companies
- 11
- Average per transaction
- $25,179
Who reported the payments
| Novartis | $2,369,813 |
| Jazz Pharmaceuticals Inc. | $324,900 |
| Coopervision Inc. | $116,322 |
| Merck | $52,577 |
| Vapotherm Inc | $19,399 |
| Takeda Pharmaceuticals U.S.A., Inc. | $6,416 |
| Cochlear Americas | $2,483 |
| Stryker | $1,744 |
| Merit Medical Systems Inc | $1,629 |
| BD | $200 |
| Convatec Inc. | $156 |